Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking

Piet van der Graaf

Articles by Piet van der Graaf

Screen Shot 2020-02-18 at 11.52.40 AM.png

Addressing the Immunogenicity Challenge

ByPiet van der Graaf,Andrzej Kierzek

February 18th 2020

Applied Clinical Trials

How modeling and simulation technology can predict and better manage immunogenicity, a key challenge for biologics drug development.

Latest Updated Articles

Addressing the Immunogenicity Challenge
February 18th 2020

Trending on Applied Clinical Trials Online

When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny

How AI Is Changing Endpoint Selection Before a Trial Even Starts

The Design Flaws Trial Simulations Surface That Traditional Planning Misses

ACT Brief: AI Expands Endpoint Options, CRO Oversight Documentation, and Kidney Cancer Approval

Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It